Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients | Zendy

Robert L. Findling | Zendy; Adelaide S. Robb | Zendy; Melissa P. DelBello | Zendy; Michael Huß | Zendy; Nora McNamara | Zendy; Elias Sarkis | Zendy; Russell E. Scheffer | Zendy; Lis H. Poulsen | Zendy; Grace Chen | Zendy; Ole Lemming | Zendy; Johan Areberg | Zendy; Philippe Auby | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients

Author(s) -

Robert L. Findling,

Adelaide S. Robb,

Melissa P. DelBello,

Michael Huß,

Nora McNamara,

Elias Sarkis,

Russell E. Scheffer,

Lis H. Poulsen,

Grace Chen,

Ole Lemming,

Johan Areberg,

Philippe Auby

Publication year - 2017

Publication title -

journal of child and adolescent psychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.935

H-Index - 84

eISSN - 1557-8992

pISSN - 1044-5463

DOI - 10.1089/cap.2016.0155

Subject(s) - vortioxetine , dosing , tolerability , medicine , adverse effect , pharmacokinetics , major depressive disorder , depression (economics) , anxiety , pediatrics , cohort , psychiatry , antidepressant , cognition , macroeconomics , economics

The primary objectives of this study were to evaluate the pharmacokinetics (PK) and tolerability of single and multiple doses of vortioxetine in children and adolescents with a depressive or anxiety disorder and to provide supportive information for appropriate dosing regimens for pediatric clinical trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research